The Mechanisms of Resistance: A Deeper Dive into Multimodal Escape in Multiple Myeloma
Episode Summary
GPRC5D-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions.